Remedy suffers stark revenue and profit decline in financial report for Q3 2025
Remedy Entertainment posted a difficult set of numbers for the third quarter of 2025, reporting a 32% year-over-year drop in revenue and a sharply wider operating loss. The loss expanded to €16.4 million, a steep increase from €2.4 million in the same quarter last year, underscoring a challenging period that has followed a leadership shake-up earlier this month.
Firebreak underperformance weighs heavily
The most significant drag on results was FBC: Firebreak, the studio’s co-op shooter that launched earlier this year. Commercial momentum has failed to materialize, and even recent updates only nudged sales upward marginally. While smaller patches and tweaks are still planned, Remedy has already shifted a portion of development staff to other projects, signaling a strategic pivot away from heavy ongoing investment in the title.
Catalog provides a partial cushion
Despite the setback, Remedy’s back catalog offered pockets of resilience. The Control and Alan Wake franchises delivered stronger sales compared to the prior year, providing a modest counterbalance to Firebreak’s shortfall. The performance suggests that interest in Remedy’s core storytelling-driven worlds remains healthy, even as newer multiplayer experiments face headwinds.
Outlook: refocus and rebuild
Management acknowledged the disappointing quarter but expressed confidence in the studio’s ability to rebound. The plan centers on concentrating resources on games with clear audience appeal and strong commercial potential, with a goal of steering the company back to profitability. The reallocation of teams away from Firebreak toward upcoming releases is a core element of that strategy.
What’s next in Remedy’s pipeline
- Control 2: The follow-up to the acclaimed action-adventure is in development, aiming to expand the series’ universe and appeal.
- Max Payne 1&2 Remake: Developed in collaboration with Rockstar Games, the modern reimagining of the classic noir shooters continues to progress.
- Unannounced project: One additional game remains in the proof-of-concept phase, with details yet to be disclosed.
As Remedy navigates a tougher-than-expected year, the path forward hinges on proven storytelling franchises and carefully managed production cycles. With a renewed focus on titles that align with the studio’s strengths, the company is betting that its upcoming slate can restore momentum after a bruising Q3.
